Production (Stage)
Lotus Bio-Technology Development Corp.
LBTD
$0.00
$0.000.00%
OTC PK
| 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 600.00 | 15.30K | 100.00 | -400.00 | 18.00K |
| Depreciation & Amortization | -- | -- | -- | -1.60K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 600.00 | 15.30K | 100.00 | -2.00K | 18.00K |
| Operating Income | -600.00 | -15.30K | -100.00 | 2.00K | -18.00K |
| Income Before Tax | -600.00 | -15.30K | -100.00 | 3.10K | -18.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -600.00 | -15.30K | -100.00 | 3.10K | -18.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -600.00 | -15.30K | -100.00 | 3.10K | -18.00K |
| EBIT | -600.00 | -15.30K | -100.00 | 2.00K | -18.00K |
| EBITDA | -- | -- | -- | -- | -11.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 334.41M | 131.69M | 82.78M | 82.78M | 82.78M |
| Average Diluted Shares Outstanding | 334.41M | 131.69M | 82.78M | 82.78M | 82.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |